Alzheimer’s drugs rejected for NHS because benefits ‘too small’ to justify cost Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. Evening Standard · Jun 18, 2025
How a hated bacteria could protect the brain from Alzheimer’s disease Helicobacter pylori – a bacteria best known for causing stomach ulcers – could lead to a new strategy in the fight against Alzheimer’s disease The Independent UK · Jun 18, 2025
Alzheimer’s: bacteria that causes stomach ulcers may protect the brain, our new research indicates Every three seconds, someone in the world develops dementia. Alzheimer’s disease is the most common form of dementia, accounting for between 60% and 70% of all cases. The Conversation · Jun 17, 2025
There's a new blood test for Alzheimer's. Here's everything you need to know about it. In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, accessible and inexpensive than other existing tests. LiveScience · Jun 12, 2025
New Alzheimer’s Blood Test Leads To Early Detection And Treatment A new Alzheimer’s blood test recently approved by the U. S. Food and Drug Administration (FDA) can now detect the disease in people with early... Saving Advice · Jun 9, 2025
Blood test for Alzheimer’s could soon be available on the NHS New study shows test is 95 per cent accurate in picking up people with memory problems The Independent UK · Jun 6, 2025
Alzheimer’s blood test ‘can accurately pick up early symptoms’ Researchers found the blood test was 95% accurate in picking up people with the disease, with very few cases missed. The Independent UK · Jun 6, 2025
Six crucial facts about Alzheimer’s and why there’s new hope for treatments There was an 11% increase in Alzheimer’s disease clinical trials scheduled for 2025 The Independent UK · Jun 3, 2025
‘Hope on the horizon’ as drugs assessed for Alzheimer’s prevention There has been an 11% increase in the number of clinical trials assessing potential treatments. Evening Standard · Jun 3, 2025
The TGA has approved donanemab for Alzheimer’s disease. How does this drug work and who will be able to access it? This week, Australia’s Therapeutic Goods Administration (TGA) approved a drug called donanemab for people in the early stages of Alzheimer’s disease. The Conversation · May 23, 2025
Australia approves new drug to treat early Alzheimer’s disease Kisunla is first new treatment registered by TGA in 25 years but could cost patients more than $80,000 and less than one in five will be eligible The Guardian - AU · May 22, 2025
Could cold sores increase the risk of Alzheimer’s disease? A new study is no cause for panic A new study has found the herpes simplex virus type 1 (HSV-1), which causes cold sores, may be linked to the development of Alzheimer’s disease. The Conversation · May 22, 2025
Scientists ‘slash risk of Alzheimer’s’ with medicine used to treat cold sores Researchers made a surprising connection between certain viral diseases and Alzheimer’s The Independent UK · May 20, 2025
Treating cold sores with anti-virals ‘may slash risk of developing Alzheimer’s’ A study found that people who had suffered the herpes virus had an 80% increased risk of Alzheimer’s disease. Evening Standard · May 20, 2025
The Conversation · May 14, 2025 Should AD stand for Alzheimer’s disease, or for Auguste Deter, the patient whose case was first described? Auguste Deter was born 175 years ago on May 16, 1850. Though the story of her life is not widely known, it should be. Through her suffering and dignity, Deter puts a much-needed human face on the tragedy of Alzheimer’s disease (AD), one of the most important medical problems currently…
The Conversation · May 14, 2025 Do people really want to know their risk of getting Alzheimer’s? A new study has highlighted the complex emotions and ethical dilemmas of learning your future risk of Alzheimer’s disease. Among 274 healthy research participants from the US aged 65 and over, 40% declined to receive their personal risk estimates – despite having initially expressed an interest in doing so.
The Conversation · May 6, 2025 Alzheimer’s: certain combinations of prescription drugs may slow progression of the disease, says mice study Millions of older adults take five or more prescription drugs every day to manage chronic illnesses. While polypharmacy is often necessary, this practice has also been linked to many negative health outcomes in older adults – including memory problems, increased risk of falls and greater frailty.
The Independent UK · May 5, 2025 How menopause symptoms could predict women’s risk of dementia ANALYSIS: Menopause can provide early warning signs, write Jasper Crockford, Maryam Ghahremani and Zahinoor Ismail
AAP · Apr 7, 2025 Diabetes drugs offer new hope for Aussies with dementia Diabetes treatments are offering a glimmer of hope for a degenerative brain condition set to affect more than 800,000 Australians by the middle of the century.
The Conversation · Mar 28, 2025 Early-onset Alzheimer’s: new drug shows promise in slowing the disease Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. Treatment options remain limited.
The Independent UK · Mar 20, 2025 New drug could reduce risk of early-onset Alzheimer’s disease The results boost hopes similar treatments being developed to target more common forms of Alzheimer's - that appear when people reach their sixties, seventies and eighties - might also be effective.
The Conversation · Mar 17, 2025 Changes to speech and language can help detect Alzheimer’s early – here are five things to look out for Ten million people are diagnosed with dementia worldwide each year – that’s more than ever. According to the Alzheimer’s Society approximately one million people in the UK are currently living with the disease. Studies predict this figure will rise to 1.6 million people by 2050.
The Guardian - US · Mar 10, 2025 Alzheimer’s research centers face Trump-imposed $65m funding delay across the US Researchers report difficulties retaining staff as White House cost-cutting stresses US medical research system
The Times of India · Mar 3, 2025 Can a 19-year-old develop Alzheimer's disease? What causes early-onset disease in young Alzheimer's disease is known to affect the elderly, and one would never expect a teenage individual to develop the neurodegenerative condition. However, this extremely rare case happened in China, and the researchers are yet to understand its underlying cause.
The Times of India · Feb 21, 2025 Could Alzheimer’s begin in your mouth? Research uncovers a potential bacterial trigger Can you get Alzheimer's disease from a gum infection? While the link may seem far-fetched, a new study has uncovered this lesser-known connection, offering clues to the roots of the neurodegenerative disease.